ClinicalTrials.Veeva

Menu

Association of Apical Periodontitis With Chronic Kidney Disease

P

Postgraduate Institute of Dental Sciences Rohtak

Status

Completed

Conditions

Chronic Kidney Diseases
Periapical Lesions

Treatments

Biological: levels of CKD markers, Oral health status, apical periodontitis
Biological: systemic inflammatory marker, Oral health status, apical periodontitis

Study type

Observational

Funder types

Other

Identifiers

NCT05818657
Dr. Jyoti Lamba

Details and patient eligibility

About

This investigation is aimed to assess the prevalence and severity of apical periodontitis (AP) in different stages of CKD patients and its impact on the systemic (nutritional and inflammatory) markers was compared to healthy individuals.

Full description

105 CKD patients (35 early (EG), 35pre-dialysis (PDG) and 35 hemodialysis (HDG)groups and 105 age and gender matched healthy controls were assessed for prevalence and severity of apical periodontitis and oral disease burden . Inflammatory (hsCRP and ferritin) and nutritional (urea and creatinine) markers were estimated and eGFR was calculated for the study population. Logistic regression was used to determine the possible association between CKD and AP in study population and Linear regression was performed to evaluate the possible association between systemic markers and endodontic burden (EB) in experimental group.

Enrollment

210 patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Known patient of CKD Stages 1,2,3,4 & 5 with estimated glomerular filtration rate [eGFR; MDRD] with mature permanent teeth.
  • > 18 years
  • > 8 natural teeth.
  • Complete medical & dental history including panoramic radiographs of maxilla & mandible

Exclusion criteria

  • Patients having systemic disorders other than CKD (eg HIV, Diabetes mellitus, Coronary heart disease, history of secondary hyperparathyroidism).
  • Pregnancy, lactation & contraceptives.
  • Systemic conditions that contra indicates dental treatment.
  • Use of antibiotics & anti-inflammatory in last 3 months
  • Need for antibiotic prophylaxis.
  • Hepatitis C and B virus.
  • Patients on steroids.

Trial design

210 participants in 2 patient groups

Group-A CKD patients
Description:
Prevalence of apical periodontitis will be checked and non-surgical root canal treatment will be given to the patients with apical periodontitis and change in PAI score, eGFR \& Systemic markers will be checked
Treatment:
Biological: levels of CKD markers, Oral health status, apical periodontitis
Group-B Healthy individuals
Description:
Prevalence of apical periodontitis will be checked and non-surgical root canal treatment will be given to the patients with apical periodontitis and change in PAI score, eGFR \& Systemic markers will be checked
Treatment:
Biological: systemic inflammatory marker, Oral health status, apical periodontitis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems